There are 2789 resources available
1219P - Study of anlotinib combined with icotinib as the first-line treatment in NSCLC patients harboring activating EGFR mutations: Updated results of ALTER-L004
Presenter: Dingzhi Huang
Session: ePoster Display
1267P - Clinical utility of ctDNA for detection of EGFR, ALK, BRAFV600E alterations and resistance mutations in patients with NSCLC at failure to targeted therapy
Presenter: Mariona Riudavets Melia
Session: ePoster Display
1148P - Identification and validation of RET fusions in lung adenocarcinoma through DNA and RNA sequencing
Presenter: Yuchen Han
Session: ePoster Display
1140P - Validation of a deep learning model for the classification of lung cancer in a large cohort of biopsied samples
Presenter: Gouji Toyokawa
Session: ePoster Display
1141P - Prediction of cancer genomic instability using MALDI-imaging
Presenter: Wanja Kassuhn
Session: ePoster Display
1142P - Improved duplex sequencing-based method suitable for detection of hypermutator phenotype in FFPE-derived tumor samples
Presenter: Natalia Mitiushkina
Session: ePoster Display
1144P - When AI-based image analysis gets in clinical trials
Presenter: Paul Mésange
Session: ePoster Display
1102P - The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses
Presenter: Philippe Ruszniewski
Session: ePoster Display
1103P - 177Lu-DOTATATE efficacy and safety in functioning neuroendocrine tumors: A joint analysis of phase II prospective clinical trials
Presenter: Alberto Bongiovanni
Session: ePoster Display